The combination of anti-ABCG2 monoclonal antibody EPI MBS+mAb and ultrasound treatment can reduce the clonal ability of MM CD138− CD34− CSC isolated from a human MM RPMI 8226 cell line and inhibit tumorigenesis in nude mice [32]. The gene discussed is ABCG2; the disease is Miyoshi myopathy.